Yahoo Web Search

  1. In that there were several things that were abnormal and after a couple of more tests we actually found out that the child had leukemia.” Thanks to CHIP, the child got into treatment ...

  2. (Atlanta, Dec. 11, 2017) -- For patients with advanced leukemia, access to high-quality end-of-life care appears to be reduced in those dependent on blood transfusions, according to a ...

  3. Today's Daily Dose brings you news about AstraZeneca's phase I/II study evaluating Acalabrutinib alone and in combination in chronic lymphocytic leukemia; bluebird's update on LentiGlobin ...

  4. DUARTE, Calif., Dec 07, 2017 (BUSINESS WIRE) -- Research about clinical trials that lay the groundwork for novel non-Hodgkin lymphoma, acute myeloid leukemia and two rare blood cancers ...

  5. ...-003 clinical trial (Abstract #432) and updated results from the Phase I/II ACE-CL-001 (Abstract #498) clinical trial that are evaluating acalabrutinib alone and in combination for the treatment of chronic lymphocytic leukemia (CLL) in multiple treatment settings.The findings were presented during two oral sessions at the 59th American Society of Hematology (ASH) Annual Meeting & Exhibition in...

  6. Romania's former King Michael I, a one-time boy monarch who later engineered the ouster of pro-Nazi strongman Gen. Ion Antonescu during World War II, only to be forced at gunpoint to abdicate ...

  7. ...2017 (BUSINESS WIRE) -- Amphivena Therapeutics Inc., a privately held biotechnology company developing AMV564, a CD33/CD3 T cell redirector for the treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), will present today in an oral presentation at the 59 [th] Annual Meeting of the American Society of Hematology preclinical data that demonstrate...

  8. University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed a software program that can accurately predict which tumor-specific markers will show up on the ...

  9. ATLANTA, Dec 11, 2017 (BUSINESS WIRE) -- City of Hope patients whose acute myeloid leukemia (AML) was no longer responding to standard therapies and a patient with a rare blood cancer ...

  10. Dillon Hill, 19, decided to leave college to complete a bucket list with his best friend, Chris Betancourt, 20, after Betancourt learned his cancer had spread. When 20-year-old Chris Betancourt ...

  1. 12345646 results